Migraine: epidemiology and systems of care M Ashina, Z Katsarava, TP Do, DC Buse, P Pozo-Rosich, A Özge, ... The Lancet 397 (10283), 1485-1495, 2021 | 452 | 2021 |
Migraine and the trigeminovascular system—40 years and counting M Ashina, JM Hansen, TP Do, A Melo-Carrillo, R Burstein, MA Moskowitz The Lancet Neurology 18 (8), 795-804, 2019 | 395 | 2019 |
Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list TP Do, A Remmers, HW Schytz, C Schankin, SE Nelson, M Obermann, ... Neurology 92 (3), 134-144, 2019 | 328 | 2019 |
Myofascial trigger points in migraine and tension-type headache TP Do, GF Heldarskard, LT Kolding, J Hvedstrup, HW Schytz The journal of headache and pain 19, 1-17, 2018 | 218 | 2018 |
Migraine: integrated approaches to clinical management and emerging treatments M Ashina, DC Buse, H Ashina, P Pozo-Rosich, MFP Peres, MJ Lee, ... The Lancet 397 (10283), 1505-1518, 2021 | 196 | 2021 |
Therapeutic novelties in migraine: new drugs, new hope? TP Do, S Guo, M Ashina The journal of headache and pain 20, 1-13, 2019 | 135 | 2019 |
Clinical features of visual migraine aura: a systematic review M Viana, EA Tronvik, TP Do, C Zecca, A Hougaard The journal of headache and pain 20, 1-7, 2019 | 102 | 2019 |
Dual therapy with anti‐CGRP monoclonal antibodies and botulinum toxin for migraine prevention: is there a rationale? L Pellesi, TP Do, H Ashina, M Ashina, R Burstein Headache: The Journal of Head and Face Pain 60 (6), 1056-1065, 2020 | 78 | 2020 |
Botulinum toxin: a review of the mode of action in migraine TP Do, J Hvedstrup, HW Schytz Acta Neurologica Scandinavica 137 (5), 442-451, 2018 | 67 | 2018 |
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis D García-Azorín, TP Do, AR Gantenbein, JM Hansen, MNP Souza, ... The journal of headache and pain 22, 1-5, 2021 | 50 | 2021 |
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study CK Cullum, TP Do, M Ashina, L Bendtsen, SS Hugger, A Iljazi, ... The Journal of Headache and Pain 23 (1), 61, 2022 | 39 | 2022 |
Green Flags and headache: A concept study using the Delphi method H Pohl, TP Do, D García‐Azorín, JM Hansen, ES Kristoffersen, SE Nelson, ... Headache: The Journal of Head and Face Pain 61 (2), 300-309, 2021 | 24 | 2021 |
Migraine and light: A narrative review AR Artemenko, E Filatova, YD Vorobyeva, TP Do, M Ashina, AB Danilov Headache: The Journal of Head and Face Pain 62 (1), 4-10, 2022 | 23 | 2022 |
The migraine landscape on YouTube: a review of YouTube as a source of information on migraine H Saffi, TP Do, JM Hansen, DW Dodick, M Ashina Cephalalgia 40 (12), 1363-1369, 2020 | 23 | 2020 |
The stereotypical image of a person with migraine according to mass media K Gvantseladze, TP Do, JM Hansen, RE Shapiro, M Ashina Headache: The Journal of Head and Face Pain 60 (7), 1465-1471, 2020 | 20 | 2020 |
Migraine attacks are of peripheral origin: the debate goes on TP Do, A Hougaard, G Dussor, KC Brennan, FM Amin The Journal of Headache and Pain 24 (1), 3, 2023 | 19 | 2023 |
Muscle stiffness in tension-type headache patients with pericranial tenderness: a shear wave elastography study LT Kolding, TP Do, C Ewertsen, HW Schytz Cephalalgia Reports 1, 2515816318760293, 2018 | 19 | 2018 |
Future prophylactic treatments in migraine: beyond anti-CGRP monoclonal antibodies and gepants TP Do, A Al-Saoudi, M Ashina Revue neurologique 177 (7), 827-833, 2021 | 18 | 2021 |
Updates in the diagnostic approach of headache TP Do, NF la Cour Karottki, M Ashina Current pain and headache reports 25 (12), 80, 2021 | 16 | 2021 |
Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without … H Ghanizada, A Iljazi, H Ashina, TP Do, MAM Al-Karagholi, FM Amin, ... Cephalalgia 41 (1), 99-111, 2021 | 16 | 2021 |